Glaxosmithkline


Horlicks out, oncology in

04/12/18 -"GSK made two major announcements on 3 December 2018. It has finally found a buyer for its nutrition drinks business. Unilever will be buying its Horlicks and other health food drinks brands in over ..."

Pages
62
Language
English
Published on
04/12/18
You may also be interested by these reports :
08/12/18
We have taken Bayer’s most recent strategy update as well as the information provided at the Investors Day into account. Our impression is that ...

04/12/18
GSK made two major announcements on 3 December 2018. It has finally found a buyer for its nutrition drinks business. Unilever will be buying its ...

04/12/18
The jittery markets continued to look for a safety-net during November 2018 and pharmas (+2.6% vs the AV universe’s -0.85%) continued to be the port ...

28/11/18
We have raised our revenue and margin estimates, following improving dynamics and the successful execution of the efficiency programme and another ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO